Creo Pharma was founded in 2007 to offer supply partners direct access to the UK generics market. Amneal Pharmaceuticals acquired Creo Pharma in 2013, and as of April 1st, 2019, it became part of Zentiva. We are a well-regarded, dependable, and growing pharmaceutical provider in the UK, with a primary focus on supplying generic medicines and commercial brands to the wholesale, pharmacy, and hospital sectors. Creo's success is based on strong client relationships, outstanding assistance, and a varied product lineup.